Live Events

The Basic Partners Program is intended to provide a solid introductory foundation for the basics of hemophilia and von Willebrand disease and increase competence to provide high quality bleeding disorder management within a multidisciplinary comprehensive care team as derived from evidence-based education, standardized guidelines, and professional networking. This activity, like all Partners Programs, is free to attend. Apply for this activity by completing the Application Form. Upon approval by your Regional Administrator, you will receive a confirmation email. You will be contacted at least 4 weeks prior to the activity with logistical details, including air and ground transportation and hotel information.

The Basic Partners Program is intended to enhance participants' knowledge of hemophilia and von Willebrand disease and increase competence to provide high quality bleeding disorder management within a multidisciplinary comprehensive care team as derived from evidence-based education, standardized guidelines, and professional networking.

At the conclusion of this live activity, the participants should be better able to:

• Describe the pathophysiology of hemophilia and von Willebrand disease (VWD), including the underlying genetics, differences by disease type and severity, basic treatments, and possible disorder-specific complications.
• Translate evidence-based assessment and management techniques during bleeding episodes and other complications associated with hemophilia and VWD
• Define a patient-/family-centered, multidisciplinary, team-based approach while caring for persons with bleeding disorders
• Discuss the organization and funding of the U.S. Hemophilia Treatment Center (HTC) network and important partnerships within the network
• Explain the roles and responsibilities of core members of the multidisciplinary bleeding disorders comprehensive care team
• Recognize the value of a professional network of nurses and other healthcare providers from HTCs to promote quality care and evidence-based practice through collaboration

Multidisciplinary clinical providers who currently are, and have been, practicing in the federally recognized U.S. Hemophilia Treatment Center (HTC) network for at least six (6) months, including, but not limited to, nurses, advanced practice providers, physical therapists, social workers, and other professionals who care for/provide services to persons with bleeding disorders.

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ANCC Credits will be offered.

To attend this program, you must meet the following criteria:

• Be employed at a U.S federally recognized HTC in a bleeding disorder patient-facing role for at least six (6) months.
• Obtain approval to attend from Regional Administrator via automated process upon submission of application.
  • Apply for this program by completing the Application Form.
  • Apply Now

• There is no registration fee to attend a Partners Program.
• Once registered, you will be contacted approximately 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
• Partners in Bleeding Disorders Education Programs are supported by education grant(s) from the following entities: Cascade Hemophilia Consortium; Sanofi; Genentech, a member of the Roche Group; Pfizer; and the Indiana Hemophilia & Thrombosis Center (IHTC).

• Upon attending any Partners in Bleeding Disorders Education Program meetings or special events, you consent to interview(s), photography, audio recording, video recording and Partners release, publication, exhibition, inclusion on websites, social media, or any other purpose by Partners and its employees or affiliates.
• Please note that your contact information as stated in your profile may be made available to program attendees. Sharing of contact information with attendees at the program you attend is for the purpose of networking with colleagues.

• January 12-14, 2026; February 16-18, 2026; April 13-15, 2026; November 16-18, 2026

Apply Now

This program aims to enable the learner to expand upon the basic hemophilia management knowledge base including pharmacological treatments, using current literature and best practice review, case study analysis, professional networking, and methods designed to raise care quality for persons with hemophilia treated within the federally recognized U.S. Hemophilia Treatment Center (HTC) network. This activity, like all Partners Programs, is free to attend. Apply for this program by completing the Application Form. Upon approval, you will receive a confirmation email. You will be contacted at least 4 weeks prior to the program with logistical details, including air and ground transportation and hotel information.

The Advanced Topics II for the Nursing Care Team aims to enable the learner to expand upon the basic hemophilia management knowledge base including pharmacological treatments, using current literature and best practice review, case study analysis, professional networking, and methods designed to raise care quality for persons with hemophilia treated within the federally recognized U.S. Hemophilia Treatment Center (HTC) network.

At the conclusion of this live activity, the participants should be better able to:

• Discuss clinical presentation, laboratory evaluation, diagnosis, and treatment of rare blood disorders including von Willebrand disease (VWD), rare bleeding disorders, thrombosis/thrombophilia, and platelet disorders
• Identify resources through which to access available information and data involving treatment products and protocols in clinical management of rare bleeding disorders
• Analyze health care team considerations related to common clinical scenarios involving persons with rare blood disorders
• Recognize the professional networks of providers from U.S. Hemophilia Treatment Centers (HTCs) to enhance clinical care quality and outcomes for persons with blood disorders treated by HTCs

Hemophilia treatment center nurses, advanced practice providers, pharmacists, and other members of the healthcare team who have treated persons with bleeding disorders for at least two (2) years.

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ANCC credits will be offered.

To attend this program, you must meet the following criteria:

• Be employed at a U.S. federally recognized HTC as a nurse, nurse practitioner, physician assistant, pharmacist or similar role for at least two (2) years.
• Obtain approval to attend from Regional Administrator via automated process upon submission of application.
  • Apply for this program by completing the Application Form.
  • Apply Now

• There is no registration fee to attend a Partners Program.
• Once registered, you will be contacted at least 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
• Partners in Bleeding Disorders Education Programs are supported by education grant(s) from the following entities: Cascade Hemophilia Consortium; Sanofi; Genentech, a member of the Roche Group; Pfizer; and the Indiana Hemophilia & Thrombosis Center (IHTC).

• Upon attending any Partners in Bleeding Disorders Education Program meetings or special events, you consent to interview(s), photography, audio recording, video recording and Partners release, publication, exhibition, inclusion on websites, social media, or any other purpose by Partners and its employees or affiliates.
• Please note that your contact information as stated in your profile may be made available to program attendees. Sharing of contact information with attendees at the program you attend is for the purpose of networking with colleagues.

• January 25-27, 2026

Apply Now